What is Integra LifeSciences's return on equity?

Integra LifeSciences (IART) reported return on equity of -38.6% in Q1 2026.

What is the long-term trend for Integra LifeSciences's return on equity?

Over 4 years (2020 to 2025), Integra LifeSciences's return on equity has grown at a 44.6% compound annual growth rate (CAGR), from 9.1% to -39.9%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Integra LifeSciences IART Return on equity

Return on equity at other companies

Becton, Dickinson and CompanyBDX

4.6%-1.3pp

AxogenAXGN

-18%-70.5pp

Globus MedicalGMED

13.3%+8.7pp

AbbVieABBV

89%+32.7pp

MedtronicMDT

9.8%+0.4pp

STERISSTE

11.3%+1.8pp

Other financials

Income statement

See full

Revenue$391.9M+2.4%

Gross profit$217.0M+11.6%

Operating income$11.5M+174%

Net income-$4.6M+81.7%

EPS (diluted)-$0.06+81.8%

Balance sheet

See full

Cash & equivalents$236.8M-1.0%

Total debt$2.0B+3.2%

Total equity$1.0B-31.6%

Total assets$3.6B-11.7%

Cash flow

See full

Operating cash flow$9.8M+187%

CapEx$14.8M-48.7%

Free cash flow-$5.0M+87.4%

Valuation

See full

Market cap$1.38B-56.8%

Enterprise value$3.12B-26.7%

P/S0.8×-1.1×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin-29.8%-30.3pp

Net margin-30.1%—

FCF margin3.8%-6.3pp

Returns & leverage

See full

Debt / equity1.9×+0.6×

Current ratio3.4×+2.2×

Where this comes from

Calculated from Integra LifeSciences’s reported figures.

net income/total stockholders equity=-38.6%

Based on trailing twelve months.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Integra LifeSciences's return on equity?: Integra LifeSciences (IART) reported return on equity of -38.6% in Q1 2026.
What is the long-term trend for Integra LifeSciences's return on equity?: Over 4 years (2020 to 2025), Integra LifeSciences's return on equity has grown at a 44.6% compound annual growth rate (CAGR), from 9.1% to -39.9%.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.